Loading clinical trials…
Loading clinical trials…
Clinical trials · failure tracking
Oncology studies whose overall status is TERMINATED, WITHDRAWN or SUSPENDED on ClinicalTrials.gov, with the stop reason exactly as the registrant posted it. A category is attached only when an explicit keyword rule matches the text; CancerIndex never infers why a study stopped.
16,112 stopped studies · 89% state a reason
Over the 16,112 studies matching the cancer, status and year filters (the category filter does not change this chart). Each study is counted once, in the first matching category; greyed bars are studies whose text matched no rule or was empty.
Computedrules ci-stop-reasons-v1 · keyword matching only
A category is assigned when one of its keywords appears in the posted text (case-insensitive, whole words). Rules are tested in this order and the first match wins; every match is kept in the API (reasonMatches).
| NCT | Title | Phase | Status | First posted | Lead sponsor | Why stopped (as posted) | Category |
|---|---|---|---|---|---|---|---|
| NCT00420862 | The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral… | Phase 3 | terminated | Jan 11, 2007 | Istituto Clinico Humanitas | not stated | Not stated |
| NCT00123877 | Study of GPX-100 in the Treatment of Metastatic Breast Cancer | Phase 2 | terminated | Jul 26, 2005 | Gem Pharmaceuticals | not stated | Not stated |
| NCT00088647 | Study Evaluating MST-997 in Advanced Malignant Solid Tumors | Phase 1 | terminated | Aug 2, 2004 | Wyeth is now a wholly owned subsidiary of Pfizer | not stated | Not stated |
| NCT00277836 | Study Evaluating MST-997 in Advanced Malignant Solid Tumors | Phase 1 | terminated | Jan 16, 2006 | Wyeth is now a wholly owned subsidiary of Pfizer | not stated | Not stated |
| NCT00152594 | Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing… | Phase 3 | terminated | Sep 9, 2005 | University of Cologne | not stated | Not stated |
| NCT00210002 | Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of… | Phase 2 | terminated | Sep 21, 2005 | Institut Claudius Regaud | not stated | Not stated |
| NCT00210028 | Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced… | Phase 2 | terminated | Sep 21, 2005 | Institut Claudius Regaud | not stated | Not stated |
| NCT00132756 | Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone… | Phase 1 / Phase 2 | terminated | Aug 22, 2005 | Morton Plant Mease Health Care | not stated | Not stated |
| NCT00104286 | Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors | Phase 1 / Phase 2 | terminated | Feb 25, 2005 | SGX Pharmaceuticals, Inc. | not stated | Not stated |
| NCT00129948 | Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) | Phase 2 | terminated | Aug 12, 2005 | SGX Pharmaceuticals, Inc. | not stated | Not stated |
| NCT00395655 | Hydralazine and Valproate Added to Chemotherapy for Breast Cancer | Phase 2 | terminated | Nov 3, 2006 | National Institute of Cancerología | not stated | Not stated |
| NCT00040170 | Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer | Phase 2 | terminated | Jun 25, 2002 | Transgene | not stated | Not stated |
| NCT00224692 | Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by… | Phase 3 | terminated | Sep 23, 2005 | Assistance Publique - Hôpitaux de Paris | not stated | Not stated |
| NCT00329498 | L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes | Phase 2 | suspended | May 24, 2006 | Samsung Medical Center | not stated | Not stated |
| NCT00241267 | Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease | — | terminated | Oct 18, 2005 | University Hospital, Tours | not stated | Not stated |
| NCT00103623 | The Plenaxis® Experience Study | Phase 4 | suspended | Feb 14, 2005 | PRAECIS Pharmaceuticals Inc. | not stated | Not stated |
| NCT00055432 | Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent… | Phase 2 | terminated | Mar 4, 2003 | Eli Lilly and Company | not stated | Not stated |
| NCT00195156 | Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies | Phase 1 | terminated | Sep 19, 2005 | Weill Medical College of Cornell University | not stated | Not stated |
| NCT00194935 | Weekly Topotecan Therapy in Patients With Ovarian Cancer | Phase 2 | terminated | Sep 19, 2005 | Weill Medical College of Cornell University | not stated | Not stated |
| NCT00220532 | Folate and Protection Against Cervical Cancer | Phase 1 / Phase 2 | terminated | Sep 22, 2005 | Sheffield Teaching Hospitals NHS Foundation Trust | not stated | Not stated |
| NCT00057343 | Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma | Phase 3 | terminated | Apr 1, 2003 | Biogen | not stated | Not stated |
| NCT00127088 | Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate… | Phase 2 | suspended | Aug 5, 2005 | Gustave Roussy, Cancer Campus, Grand Paris | not stated | Not stated |
| NCT00176761 | Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine | Phase 2 | terminated | Sep 15, 2005 | University of Michigan Rogel Cancer Center | not stated | Not stated |
| NCT00180830 | Glivec Phase II Pediatric Study | Phase 2 | terminated | Sep 16, 2005 | Gustave Roussy, Cancer Campus, Grand Paris | not stated | Not stated |
| NCT00180895 | Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL | Phase 2 | terminated | Sep 16, 2005 | Gustave Roussy, Cancer Campus, Grand Paris | not stated | Not stated |
| NCT00180960 | Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery… | Phase 2 | terminated | Sep 16, 2005 | Gustave Roussy, Cancer Campus, Grand Paris | not stated | Not stated |
| NCT00355212 | Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of… | Phase 3 | terminated | Jul 21, 2006 | Azienda Ospedaliera San Giovanni Battista | not stated | Not stated |
| NCT00051688 | Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal… | Phase 2 | terminated | Jan 16, 2003 | Chiron Corporation | not stated | Not stated |
| NCT00337506 | Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple… | Phase 2 | terminated | Jun 16, 2006 | Nantes University Hospital | not stated | Not stated |
| NCT00114946 | A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic… | Phase 4 | terminated | Jun 21, 2005 | Genentech, Inc. | not stated | Not stated |
| NCT00209703 | Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer | Phase 2 | terminated | Sep 21, 2005 | Hokkaido Gastrointestinal Cancer Study Group | not stated | Not stated |
| NCT00179725 | Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And… | Phase 1 / Phase 2 | terminated | Sep 16, 2005 | Celgene Corporation | not stated | Not stated |
| NCT00309517 | Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C | Phase 3 | terminated | Apr 3, 2006 | Austrian Breast & Colorectal Cancer Study Group | not stated | Not stated |
| NCT00303407 | Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care | — | terminated | Mar 16, 2006 | University Hospital, Geneva | not stated | Not stated |
| NCT00101621 | Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With… | Phase 2 | terminated | Jan 13, 2005 | MetaPhore Pharmaceuticals | not stated | Not stated |
| NCT00100737 | Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in… | Phase 2 | terminated | Jan 7, 2005 | Chiron Corporation | not stated | Not stated |
| NCT00103428 | Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic… | Phase 1 / Phase 2 | terminated | Feb 9, 2005 | Cell Genesys | not stated | Not stated |
| NCT00209664 | Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer | Phase 2 | suspended | Sep 21, 2005 | Hokkaido Gastrointestinal Cancer Study Group | not stated | Not stated |
| NCT00151645 | Efficacy of Activated Lymphocytes in Renal Cell Carcinoma. | Phase 2 | terminated | Sep 9, 2005 | Rennes University Hospital | not stated | Not stated |
| NCT00219765 | Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute… | Phase 1 / Phase 2 | terminated | Sep 22, 2005 | Poitiers University Hospital | not stated | Not stated |
| NCT00179738 | A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of… | Phase 2 | terminated | Sep 16, 2005 | Celgene Corporation | not stated | Not stated |
| NCT00179699 | Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To… | Phase 1 | terminated | Sep 16, 2005 | Celgene Corporation | not stated | Not stated |
| NCT00179751 | A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With… | Phase 1 / Phase 2 | terminated | Sep 16, 2005 | Celgene Corporation | not stated | Not stated |
| NCT00211952 | Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients | Phase 3 | suspended | Sep 21, 2005 | Medical University of Gdansk | not stated | Not stated |
| NCT00189371 | Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin… | Phase 3 | terminated | Sep 19, 2005 | AGO Study Group | not stated | Not stated |
| NCT00169169 | Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma | Phase 3 | terminated | Sep 15, 2005 | Lymphoma Study Association | not stated | Not stated |
| NCT00162695 | Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood | Phase 3 | terminated | Sep 13, 2005 | Gustave Roussy, Cancer Campus, Grand Paris | not stated | Not stated |
| NCT00160992 | Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed… | Phase 1 | suspended | Sep 12, 2005 | University of Lausanne Hospitals | not stated | Not stated |
| NCT00083473 | A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia | Phase 2 | terminated | May 26, 2004 | Titan Pharmaceuticals | not stated | Not stated |
| NCT00087477 | A Pilot Study of Pivanex in Patients With Malignant Melanoma | Phase 1 / Phase 2 | terminated | Jul 13, 2004 | Titan Pharmaceuticals | not stated | Not stated |
Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.
Data updated 22 days agoSource updated Jan 11, 2007source: clinicaltrials